JAMA Neurology (Journal)

Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug

Safety data from those trials was published Monday in the journal JAMA Neurology in a study whose authors included eight Biogen employees. The data showed that 425 of 1,029 patients, or 41 percent, who received the high dose of the drug — the dose that the F.D.A. later approved — experienced either brain swelling or […]

Read More